“…Collagen I, II and inflammatory infiltrate levels were analysed at implant site 7, 30 and 90 | Coating PP mesh with platelet-rich plasma enhanced tissue regeneration with higher total collagen concentration | Promising results; however, it is unclear if these histology outcomes will result in better clinical outcomes | Brazil | Avila et al [ 34 ] | Mesh B: mesh A coated with platelet-rich plasma extracted from blood via centrifuge |
Rabbit | Mesh A: PP mesh | Abdominal wall | Meshes C and D were compared as alternative materials to commercially available Meshes A and B. Implants were placed in full-thickness abdominal wall defects | 30 and 90 | Meshes C and D had better outcomes, with decreased inflammatory response | Promising results regarding alternative materials; however, these would need replication in larger animal models | Belgium and UK | Sabiniano et al [ 35 ] |
Mesh B: PVDF mesh |
Mesh C: polyurethane mesh |
Mesh D: poly-L-lactic acid |
Sheep | EndoFast Reliant™ System | Thigh fascia | EndoFast Reliant™ System was used to insert mesh into sheep thigh fascia. Pullout force was measured at each endpoint | 0, 3, 7, 15, 30 and 45 | Test to investigate the strength of attachment; results showed that the experimental system provided much stronger mesh attachment than trocar-based methods | Sheep thigh was used as the site of implantation owing to histological similarity, rather than vagina tissue | Israel | Alcalay et al [ 36 ] |
Only papers written in English language were included in the table eMSCs endometrial mesenchymal stem cells, ME mesh exposure, NHP non-human primate, NZW New Zealand White, PCL poly ε-caprolactone, PCU polycarbonate urethane, PDMS polydimethylsiloxane, POP pelvic organ prolapse, PP polypropylene, PVDF polyvinylidene fluoride, SD Sprague–Dawley …”